ScholarIQanswers from OpenAlex

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies

PaperCitations, authors & open-access status

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies have?

ScholarIQcitation count

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies has 342 citations in the OpenAlex counts ScholarIQ stores.

When was Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies published?

ScholarIQyear

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies has 2011 year in the ScholarIQ index.

What is the open-access status of Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies?

ScholarIQoa status

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies has closed oa status in the ScholarIQ index.

What is the DOI of Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies?

ScholarIQdoi

The DOI for Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies is on the source record.

What is the PMID of Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies?

ScholarIQpmid

The PMID for Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies is on the source record.

What is the OpenAlex record for Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies?

ScholarIQopenalex

The OpenAlex for Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial